サンプル依頼リスト カート
  • English
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1745009

バイオ医薬品物流の世界市場

Bio-pharma Logistics

出版日
ページ情報
英文 231 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.35円
バイオ医薬品物流の世界市場
出版日: 2025年06月06日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 231 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

バイオ医薬品物流の世界市場は2030年までに1,729億米ドルに達する見込み

2024年に1,096億米ドルと推定されるバイオ医薬品物流の世界市場は、2030年には1,729億米ドルに達し、分析期間2024-2030年のCAGRは7.9%で成長すると予測されます。本レポートで分析したセグメントの一つであるコールドチェーン物流は、CAGR6.4%を記録し、分析期間終了時には1,042億米ドルに達すると予測されます。非コールドチェーンロジスティクスセグメントの成長率は、分析期間中CAGR 10.4%と推定されます。

米国市場は288億米ドルと推定、中国はCAGR7.7%で成長予測

米国のバイオ医薬品物流市場は2024年に288億米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに278億米ドルの市場規模に達すると予測され、分析期間2024-2030年のCAGRは7.7%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ7.0％と6.8％と予測されています。欧州では、ドイツがCAGR約6.5％で成長すると予測されています。

世界のバイオ医薬品物流市場- 主要動向と促進要因のまとめ

バイオ医薬品物流が製品の完全性、コールドチェーンコンプライアンス、世界な治療リーチの戦略的柱として台頭している理由とは？

バイオ医薬品物流は、ライフサイエンスのバリューチェーンにおけるミッションクリティカルな機能へと進化し、高価値医薬品、生物製剤、ワクチン、細胞・遺伝子治療薬の安全でタイムリーな温度管理された流通を支えています。製品の複雑さと繊細さが増す中、ロジスティクスは現在、治療効果、規制遵守、市場参入を守る上で中心的な役割を担っています。ファーストマイルの原薬輸送からラストマイルの臨床配送に至るまで、ロジスティクスプロバイダーはより広範な商業化と供給継続戦略に組み込まれつつあります。

モノクローナル抗体、mRNAワクチン、CAR-T療法など、温度に敏感な生物製剤の台頭は、エンド・ツー・エンドのコールドチェーン・ロジスティクスの重要性を高めています。これらの製品は厳しい温度範囲（通常2～8℃、-20℃、あるいは-80℃の極低温保存）を必要とし、製品の生存性を損なう可能性のある温度逸脱を防ぐため、リアルタイムで監視する必要があります。臨床試験の分散化、患者への直接投与モデル、世界のワクチンプログラムの拡大により、ロジスティクスのインフラ、可視性、トレーサビリティに対する要求はさらに高まっています。

温度管理だけでなく、バイオ医薬品物流は製品の保存期間、規制の調和、通関、輸送中のセキュリティに関する課題にも対処しなければならないです。生物製剤や先端治療薬は経済的、治療的に高い価値を持つため、ロジスティクスチェーンに混乱が生じると、臨床的、経済的に多大な影響を及ぼす可能性があります。その結果、製薬会社はロジスティクスを戦略的な能力として再評価しており、コストだけでなく、品質保証、コンプライアンスの強さ、技術的な即応性によってパートナーを選択しています。

コールドチェーン技術、リアルタイムの可視化、リスク軽減戦略は、バイオ製薬におけるロジスティクス能力をどのように形成しているのでしょうか。

コールドチェーンの革新は、ロジスティクス変革の最前線にあります。相変化材料、真空断熱包装パネル、再利用可能なサーマルシッパーなどの先進パッケージングソリューションは、長時間の輸送や様々な気候条件下でも温度を維持するために導入されています。超低温の安定性が譲れない細胞治療や遺伝子治療の輸送には、乾燥蒸気窒素技術を用いた極低温コンテナの使用が増加しています。

IoT対応データロガー、GPSトラッカー、クラウドベースのダッシュボードにより、場所、温度、衝撃、光、湿度に関する詳細な洞察が得られます。これらのツールにより、ロジスティクスマネージャーは、逸脱が発生した場合にプロアクティブに介入し、機密性の高い貨物を迂回させ、規制文書化のための監査証跡を維持することができます。倉庫管理システム（WMS）、輸送管理システム（TMS）、ブロックチェーンベースのプラットフォームとの統合は、トレーサビリティとCoCの保証をさらに強化します。

リスクの軽減は、特にリスクの高い地域やパンデミックレベルの混乱時における、バイオ医薬品物流の重要な優先事項です。コンティンジェンシープランニング、ルートクオリフィケーション、デュアルベンダーコールドチェーンセットアップ、冗長保管ノードは、供給の継続性を確保するためのロジスティクス戦略にますます組み込まれつつあります。FDA、EMA、WHOなどの規制機関は、輸送バリデーション、温度マッピング、逸脱対応プロトコルについて、より厳格な管理を義務付けており、GxPに準拠したオペレーションと医薬品グレードの品質システムを持つロジスティクスパートナーの必要性を高めています。

特化したバイオ医薬品物流の需要を牽引する治療分野、世界流通ネットワーク、戦略的パートナーシップとは？

細胞治療や遺伝子治療、個別化がんワクチン、RNAベースの生物製剤などの先端治療が、バイオ医薬品物流市場の主な成長要因です。これらの治療法は、多くの場合、実行可能性が狭く、ジャストインタイムのデリバリーモデルを必要とし、世界の患者基盤を持つ集中施設で生産されます。免疫腫瘍学、希少疾患、次世代ワクチンなどの臨床試験の急増は、ロジスティクス・チェーンを通過する生物製剤の量と複雑さをさらに増大させています。

世界な物流ネットワークは、アジア太平洋、中東、ラテンアメリカの新興バイオクラスターからの需要に適応しつつあり、これらのバイオクラスターは製造および臨床試験事業を拡大しています。GDP認定施設、地域冷蔵倉庫、マルチモーダル統合を備えた物流ハブは、輸送リスクを軽減し、治療までの時間を短縮するために戦略的に設立されつつあります。北米と西欧は依然として中心的な拠点であるが、製造の分散化と現地化は、より機敏で分散型のロジスティクス・アーキテクチャへのシフトを促しています。

製薬会社、3PLプロバイダー、包装ベンダー、テクノロジーイネーブラー間の戦略的パートナーシップは、ロジスティクスのエコシステムを再定義しつつあります。ルート検証プロトコル、共有リスクモデル、デジタル統合プラットフォームの共同開発により、エンド・ツー・エンドの可視化とパフォーマンスに基づくロジスティクス管理が可能になりつつあります。製薬メーカーがよりスリムで需要主導型のサプライチェーンに移行するにつれ、ロジスティクス・パートナーは計画サイクルの早い段階で組み込まれ、特定の治療プロファイルや規制経路に合わせたソリューションを共同設計するようになっています。

バイオ医薬品物流市場の成長要因は？

バイオ医薬品物流市場は、ライフサイエンス分野が、高精度で準拠性の高いロジスティクスソリューションを必要とする、複雑で温度変化に敏感な、患者中心の治療法へと移行するにつれて拡大しています。ロジスティクスは今や、治療の成功、患者の安全性、商業的な拡張性を実現する重要な要素となっています。

主な成長促進要因としては、コールドチェーンに依存する生物製剤や先端治療薬の普及、国際共同治験の拡大、エンド・ツー・エンドの可視性に対する規制当局の義務付け、分散型で機敏な配送モデルに対する需要の高まりなどが挙げられます。技術革新、戦略的アウトソーシング、垂直統合型サービスモデルは、市場の進化をさらに加速させています。

バイオ医薬品のパイプラインが個別化された高価値の治療薬へとシフトする中、ロジスティクスが競争上の差別化要因となり、バックエンド機能から、価値を生み出し、リスクを軽減し、イノベーションに沿った次世代医薬品デリバリーの柱へと変貌を遂げる可能性はあるのだろうか。

セグメント

タイプ（コールドチェーンロジスティクス、非コールドチェーンロジスティクス）、サービスタイプ（輸送、倉庫保管、包装、その他サービスタイプ）、用途（生物製剤、医療用医薬品、一般用医薬品、原料・原薬、その他用途）

調査対象企業の例（全42社）

  • Agility Logistics
  • Air Canada Cargo
  • AmerisourceBergen Corporation
  • Biocair
  • Cavalier Logistics
  • CEVA Logistics
  • DB Schenker
  • DHL Global Forwarding
  • FedEx Corporation
  • Kerry Logistics Network Limited
  • Kuehne+Nagel
  • LifeConEx
  • Marken（a UPS Company）
  • Nippon Express
  • SF Express
  • Sofrigam Group
  • United Parcel Service（UPS）
  • VersaCold Logistics Services
  • World Courier
  • Yusen Logistics

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、人為的な売上原価の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

Global Industry Analystsは、世界の主要なチーフ・エコノミスト（1万4,949人）、シンクタンク（62団体）、貿易・産業団体（171団体）の専門家の意見に熱心に従いながら、エコシステムへの影響を評価し、新たな市場の現実に対処しています。あらゆる主要国の専門家やエコノミストが、関税とそれが自国に与える影響についての意見を追跡調査しています。

Global Industry Analystsは、この混乱が今後2-3ヶ月で収束し、新しい世界秩序がより明確に確立されると予想しています。Global Industry Analystsは、これらの開発をリアルタイムで追跡しています。

2025年4月：交渉フェーズ

4月のリリースでは、世界市場全体に対する関税の影響を取り上げ、地域別の市場調整について紹介します。当社の予測は、過去のデータと進化する市場影響要因に基づいています。

2025年7月：最終関税リセット

お客様には、各国間で最終リセットが発表された後、7月に無料アップデート版をお届けします。最終アップデート版には、明確に定義された関税影響分析が組み込まれています。

相互および二国間貿易と関税の影響分析：

アメリカ <>中国<>メキシコ <>カナダ <>EU <>日本<>インド <>その他176カ国

業界をリードするエコノミスト：Global Industry Analystsの知識ベースは、国家、シンクタンク、貿易・産業団体、大企業、そして世界の計量経済状況におけるこの前例のないパラダイムシフトの影響を共有する領域の専門家など、最も影響力のあるチーフエコノミストの厳選されたグループを含む1万4,949人のエコノミストを追跡しています。我々の16,491以上のレポートのほとんどは、マイルストーンに基づくこの2段階のリリーススケジュールを取り入れています。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • その他欧州
  • アジア太平洋
  • その他の地域

第4章 競合

目次
Product Code: MCP34706

Global Bio-pharma Logistics Market to Reach US$172.9 Billion by 2030

The global market for Bio-pharma Logistics estimated at US$109.6 Billion in the year 2024, is expected to reach US$172.9 Billion by 2030, growing at a CAGR of 7.9% over the analysis period 2024-2030. Cold Chain Logistics, one of the segments analyzed in the report, is expected to record a 6.4% CAGR and reach US$104.2 Billion by the end of the analysis period. Growth in the Non-Cold Chain Logistics segment is estimated at 10.4% CAGR over the analysis period.

The U.S. Market is Estimated at US$28.8 Billion While China is Forecast to Grow at 7.7% CAGR

The Bio-pharma Logistics market in the U.S. is estimated at US$28.8 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$27.8 Billion by the year 2030 trailing a CAGR of 7.7% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 7.0% and 6.8% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 6.5% CAGR.

Global Bio-pharma Logistics Market - Key Trends & Drivers Summarized

Why Is Bio-pharma Logistics Emerging as a Strategic Pillar for Product Integrity, Cold Chain Compliance, and Global Therapeutic Reach?

Bio-pharma logistics has evolved into a mission-critical function within the life sciences value chain, underpinning the secure, timely, and temperature-controlled distribution of high-value pharmaceuticals, biologics, vaccines, and cell and gene therapies. With increasing product complexity and sensitivity, logistics now plays a central role in safeguarding therapeutic efficacy, regulatory compliance, and market access. From first-mile API transport to last-mile clinical delivery, logistics providers are being integrated into broader commercialization and supply continuity strategies.

The rise of temperature-sensitive biologics-including monoclonal antibodies, mRNA vaccines, and CAR-T therapies-has amplified the importance of end-to-end cold chain logistics. These products require stringent temperature ranges (typically 2-8°C, -20°C, or even cryogenic storage at -80°C) and must be monitored in real time to prevent thermal excursions that can compromise product viability. The expansion of decentralized clinical trials, direct-to-patient delivery models, and global vaccine programs has placed further demands on logistics infrastructure, visibility, and traceability.

Beyond temperature control, bio-pharma logistics must address challenges related to product shelf life, regulatory harmonization, customs clearance, and security in transit. With biologics and advanced therapies commanding high economic and therapeutic value, any disruption in the logistics chain can have far-reaching clinical and financial consequences. As a result, pharmaceutical companies are re-evaluating logistics as a strategic capability-selecting partners not just on cost but on quality assurance, compliance strength, and technological readiness.

How Are Cold Chain Technologies, Real-Time Visibility, and Risk Mitigation Strategies Reshaping Logistics Capabilities in Bio-pharma?

Cold chain innovation is at the forefront of logistics transformation. Advanced packaging solutions-such as phase-change materials, vacuum-insulated panels, and reusable thermal shippers-are being deployed to maintain temperature integrity over extended transit times and varied climatic conditions. Cryogenic containers with dry vapor nitrogen technology are increasingly used for cell and gene therapy shipments, where ultra-low temperature stability is non-negotiable.

Real-time visibility tools are becoming standard across critical lanes, with IoT-enabled data loggers, GPS trackers, and cloud-based dashboards providing granular insights into location, temperature, shock, light, and humidity. These tools allow logistics managers to intervene proactively in case of deviations, reroute sensitive shipments, and maintain audit trails for regulatory documentation. Integration with warehouse management systems (WMS), transport management systems (TMS), and blockchain-based platforms further enhances traceability and chain-of-custody assurance.

Risk mitigation is a key priority in bio-pharma logistics, particularly in high-risk geographies or during pandemic-level disruptions. Contingency planning, route qualification, dual-vendor cold chain setups, and redundant storage nodes are increasingly embedded in logistics strategies to ensure continuity of supply. Regulatory agencies such as the FDA, EMA, and WHO are mandating stricter controls on transport validation, temperature mapping, and deviation response protocols-reinforcing the need for logistics partners with GxP-compliant operations and pharmaceutical-grade quality systems.

Which Therapeutic Segments, Global Distribution Networks, and Strategic Partnerships Are Driving Demand for Specialized Bio-pharma Logistics?

Advanced therapies-including cell and gene therapies, personalized cancer vaccines, and RNA-based biologics-are the primary growth drivers in the bio-pharma logistics market. These therapies often have narrow windows of viability, require just-in-time delivery models, and are produced in centralized facilities with global patient bases. The surge in clinical trials across immuno-oncology, rare diseases, and next-generation vaccines is further increasing the volume and complexity of biologics moving through the logistics chain.

Global distribution networks are adapting to meet demand from emerging bio-clusters in Asia-Pacific, the Middle East, and Latin America, which are expanding manufacturing and clinical trial operations. Logistics hubs with GDP-certified facilities, regional cold storage, and multi-modal integration are being strategically established to reduce transit risk and enable faster time-to-therapy. North America and Western Europe remain central nodes, but decentralization and localization of manufacturing are prompting a shift toward more agile and distributed logistics architectures.

Strategic partnerships between pharma companies, 3PL providers, packaging vendors, and technology enablers are redefining the logistics ecosystem. Co-development of route validation protocols, shared risk models, and digital integration platforms is enabling end-to-end visibility and performance-based logistics management. As pharma manufacturers move toward leaner, demand-driven supply chains, logistics partners are being embedded earlier in planning cycles to co-design solutions tailored to specific therapy profiles and regulatory pathways.

What Are the Factors Driving Growth in the Bio-pharma Logistics Market?

The bio-pharma logistics market is expanding as the life sciences sector transitions toward complex, temperature-sensitive, and patient-centric therapies that demand high-precision, compliant logistics solutions. Logistics is now a critical enabler of therapeutic success, patient safety, and commercial scalability.

Key growth drivers include the proliferation of cold chain-dependent biologics and advanced therapies, expanding global clinical trials, regulatory mandates for end-to-end visibility, and rising demand for decentralized, agile delivery models. Technological innovation, strategic outsourcing, and vertically integrated service models are further accelerating market evolution.

As biopharma pipelines shift toward individualized, high-value therapeutics, could logistics become the competitive differentiator-transforming from a backend function into a value-generating, risk-mitigating, and innovation-aligned pillar of next-generation pharmaceutical delivery?

SCOPE OF STUDY:

The report analyzes the Bio-pharma Logistics market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Type (Cold Chain Logistics, Non-Cold Chain Logistics); Service Type (Transportation, Warehousing, Packaging, Other Service Types); Application (Biologics, Prescribed Drugs, Over-the-Counter Medicines, Raw Materials & Bulk Pharmaceuticals, Other Applications)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 42 Featured) -

  • Agility Logistics
  • Air Canada Cargo
  • AmerisourceBergen Corporation
  • Biocair
  • Cavalier Logistics
  • CEVA Logistics
  • DB Schenker
  • DHL Global Forwarding
  • FedEx Corporation
  • Kerry Logistics Network Limited
  • Kuehne + Nagel
  • LifeConEx
  • Marken (a UPS Company)
  • Nippon Express
  • SF Express
  • Sofrigam Group
  • United Parcel Service (UPS)
  • VersaCold Logistics Services
  • World Courier
  • Yusen Logistics

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by artificially increasing the COGS, reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

We are diligently following expert opinions of leading Chief Economists (14,949), Think Tanks (62), Trade & Industry bodies (171) worldwide, as they assess impact and address new market realities for their ecosystems. Experts and economists from every major country are tracked for their opinions on tariffs and how they will impact their countries.

We expect this chaos to play out over the next 2-3 months and a new world order is established with more clarity. We are tracking these developments on a real time basis.

As we release this report, U.S. Trade Representatives are pushing their counterparts in 183 countries for an early closure to bilateral tariff negotiations. Most of the major trading partners also have initiated trade agreements with other key trading nations, outside of those in the works with the United States. We are tracking such secondary fallouts as supply chains shift.

To our valued clients, we say, we have your back. We will present a simplified market reassessment by incorporating these changes!

APRIL 2025: NEGOTIATION PHASE

Our April release addresses the impact of tariffs on the overall global market and presents market adjustments by geography. Our trajectories are based on historic data and evolving market impacting factors.

JULY 2025 FINAL TARIFF RESET

Complimentary Update: Our clients will also receive a complimentary update in July after a final reset is announced between nations. The final updated version incorporates clearly defined Tariff Impact Analyses.

Reciprocal and Bilateral Trade & Tariff Impact Analyses:

USA <> CHINA <> MEXICO <> CANADA <> EU <> JAPAN <> INDIA <> 176 OTHER COUNTRIES.

Leading Economists - Our knowledge base tracks 14,949 economists including a select group of most influential Chief Economists of nations, think tanks, trade and industry bodies, big enterprises, and domain experts who are sharing views on the fallout of this unprecedented paradigm shift in the global econometric landscape. Most of our 16,491+ reports have incorporated this two-stage release schedule based on milestones.

COMPLIMENTARY PREVIEW

Contact your sales agent to request an online 300+ page complimentary preview of this research project. Our preview will present full stack sources, and validated domain expert data transcripts. Deep dive into our interactive data-driven online platform.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Bio-pharma Logistics - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Global Demand for Temperature-Sensitive Biologics Throws the Spotlight on Specialized Bio-Pharma Logistics
    • Growth in Cell and Gene Therapy Markets Spurs Investment in Ultra-Cold Chain and Cryogenic Transportation
    • OEM Integration of Real-Time Monitoring and GPS Tracking Technologies Enhances Shipment Visibility and Integrity
    • Expansion of Just-in-Time Manufacturing and Direct-to-Patient Delivery Models Fuels Demand for Agile Logistics
    • OEM Focus on Lane Qualification, Regulatory Compliance, and GDP Certification Strengthens Provider Credibility
    • Growth in Biologics and Clinical Trial Logistics Drives Need for Time-Critical, High-Compliance Transport Networks
    • Adoption of Blockchain and Data Logging Solutions Enhances Chain-of-Custody Verification
    • Strategic Placement of Biopharma Logistics Hubs Near Manufacturing and Clinical Trial Centers Improves Responsiveness
    • Rise of Biopharma Outsourcing and Global CDMO Partnerships Supports 3PL and 4PL Market Expansion
    • Investment in Reverse Logistics and Packaging Reusability Supports Sustainability Goals in Pharmaceutical Transport
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Bio-pharma Logistics Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Bio-pharma Logistics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Bio-pharma Logistics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Bio-pharma Logistics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Cold Chain Logistics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Cold Chain Logistics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Cold Chain Logistics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Non-Cold Chain Logistics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Non-Cold Chain Logistics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Non-Cold Chain Logistics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Raw Materials & Bulk Pharmaceuticals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Raw Materials & Bulk Pharmaceuticals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Raw Materials & Bulk Pharmaceuticals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Biologics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Biologics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Biologics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Prescribed Drugs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Prescribed Drugs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Prescribed Drugs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Over-the-Counter Medicines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Over-the-Counter Medicines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Over-the-Counter Medicines by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Transportation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Transportation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 28: World 15-Year Perspective for Transportation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Warehousing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Warehousing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 31: World 15-Year Perspective for Warehousing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Packaging by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Packaging by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 34: World 15-Year Perspective for Packaging by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 35: World Recent Past, Current & Future Analysis for Other Service Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 36: World Historic Review for Other Service Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 37: World 15-Year Perspective for Other Service Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Bio-pharma Logistics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 38: USA Recent Past, Current & Future Analysis for Bio-pharma Logistics by Type - Cold Chain Logistics and Non-Cold Chain Logistics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: USA Historic Review for Bio-pharma Logistics by Type - Cold Chain Logistics and Non-Cold Chain Logistics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 40: USA 15-Year Perspective for Bio-pharma Logistics by Type - Percentage Breakdown of Value Sales for Cold Chain Logistics and Non-Cold Chain Logistics for the Years 2015, 2025 & 2030
    • TABLE 41: USA Recent Past, Current & Future Analysis for Bio-pharma Logistics by Application - Raw Materials & Bulk Pharmaceuticals, Other Applications, Biologics, Prescribed Drugs and Over-the-Counter Medicines - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 42: USA Historic Review for Bio-pharma Logistics by Application - Raw Materials & Bulk Pharmaceuticals, Other Applications, Biologics, Prescribed Drugs and Over-the-Counter Medicines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 43: USA 15-Year Perspective for Bio-pharma Logistics by Application - Percentage Breakdown of Value Sales for Raw Materials & Bulk Pharmaceuticals, Other Applications, Biologics, Prescribed Drugs and Over-the-Counter Medicines for the Years 2015, 2025 & 2030
    • TABLE 44: USA Recent Past, Current & Future Analysis for Bio-pharma Logistics by Service Type - Transportation, Warehousing, Packaging and Other Service Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: USA Historic Review for Bio-pharma Logistics by Service Type - Transportation, Warehousing, Packaging and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 46: USA 15-Year Perspective for Bio-pharma Logistics by Service Type - Percentage Breakdown of Value Sales for Transportation, Warehousing, Packaging and Other Service Types for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 47: Canada Recent Past, Current & Future Analysis for Bio-pharma Logistics by Type - Cold Chain Logistics and Non-Cold Chain Logistics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Canada Historic Review for Bio-pharma Logistics by Type - Cold Chain Logistics and Non-Cold Chain Logistics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 49: Canada 15-Year Perspective for Bio-pharma Logistics by Type - Percentage Breakdown of Value Sales for Cold Chain Logistics and Non-Cold Chain Logistics for the Years 2015, 2025 & 2030
    • TABLE 50: Canada Recent Past, Current & Future Analysis for Bio-pharma Logistics by Application - Raw Materials & Bulk Pharmaceuticals, Other Applications, Biologics, Prescribed Drugs and Over-the-Counter Medicines - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Canada Historic Review for Bio-pharma Logistics by Application - Raw Materials & Bulk Pharmaceuticals, Other Applications, Biologics, Prescribed Drugs and Over-the-Counter Medicines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 52: Canada 15-Year Perspective for Bio-pharma Logistics by Application - Percentage Breakdown of Value Sales for Raw Materials & Bulk Pharmaceuticals, Other Applications, Biologics, Prescribed Drugs and Over-the-Counter Medicines for the Years 2015, 2025 & 2030
    • TABLE 53: Canada Recent Past, Current & Future Analysis for Bio-pharma Logistics by Service Type - Transportation, Warehousing, Packaging and Other Service Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Canada Historic Review for Bio-pharma Logistics by Service Type - Transportation, Warehousing, Packaging and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 55: Canada 15-Year Perspective for Bio-pharma Logistics by Service Type - Percentage Breakdown of Value Sales for Transportation, Warehousing, Packaging and Other Service Types for the Years 2015, 2025 & 2030
  • JAPAN
    • Bio-pharma Logistics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 56: Japan Recent Past, Current & Future Analysis for Bio-pharma Logistics by Type - Cold Chain Logistics and Non-Cold Chain Logistics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Japan Historic Review for Bio-pharma Logistics by Type - Cold Chain Logistics and Non-Cold Chain Logistics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 58: Japan 15-Year Perspective for Bio-pharma Logistics by Type - Percentage Breakdown of Value Sales for Cold Chain Logistics and Non-Cold Chain Logistics for the Years 2015, 2025 & 2030
    • TABLE 59: Japan Recent Past, Current & Future Analysis for Bio-pharma Logistics by Application - Raw Materials & Bulk Pharmaceuticals, Other Applications, Biologics, Prescribed Drugs and Over-the-Counter Medicines - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Japan Historic Review for Bio-pharma Logistics by Application - Raw Materials & Bulk Pharmaceuticals, Other Applications, Biologics, Prescribed Drugs and Over-the-Counter Medicines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 61: Japan 15-Year Perspective for Bio-pharma Logistics by Application - Percentage Breakdown of Value Sales for Raw Materials & Bulk Pharmaceuticals, Other Applications, Biologics, Prescribed Drugs and Over-the-Counter Medicines for the Years 2015, 2025 & 2030
    • TABLE 62: Japan Recent Past, Current & Future Analysis for Bio-pharma Logistics by Service Type - Transportation, Warehousing, Packaging and Other Service Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Japan Historic Review for Bio-pharma Logistics by Service Type - Transportation, Warehousing, Packaging and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 64: Japan 15-Year Perspective for Bio-pharma Logistics by Service Type - Percentage Breakdown of Value Sales for Transportation, Warehousing, Packaging and Other Service Types for the Years 2015, 2025 & 2030
  • CHINA
    • Bio-pharma Logistics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 65: China Recent Past, Current & Future Analysis for Bio-pharma Logistics by Type - Cold Chain Logistics and Non-Cold Chain Logistics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: China Historic Review for Bio-pharma Logistics by Type - Cold Chain Logistics and Non-Cold Chain Logistics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 67: China 15-Year Perspective for Bio-pharma Logistics by Type - Percentage Breakdown of Value Sales for Cold Chain Logistics and Non-Cold Chain Logistics for the Years 2015, 2025 & 2030
    • TABLE 68: China Recent Past, Current & Future Analysis for Bio-pharma Logistics by Application - Raw Materials & Bulk Pharmaceuticals, Other Applications, Biologics, Prescribed Drugs and Over-the-Counter Medicines - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: China Historic Review for Bio-pharma Logistics by Application - Raw Materials & Bulk Pharmaceuticals, Other Applications, Biologics, Prescribed Drugs and Over-the-Counter Medicines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 70: China 15-Year Perspective for Bio-pharma Logistics by Application - Percentage Breakdown of Value Sales for Raw Materials & Bulk Pharmaceuticals, Other Applications, Biologics, Prescribed Drugs and Over-the-Counter Medicines for the Years 2015, 2025 & 2030
    • TABLE 71: China Recent Past, Current & Future Analysis for Bio-pharma Logistics by Service Type - Transportation, Warehousing, Packaging and Other Service Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: China Historic Review for Bio-pharma Logistics by Service Type - Transportation, Warehousing, Packaging and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 73: China 15-Year Perspective for Bio-pharma Logistics by Service Type - Percentage Breakdown of Value Sales for Transportation, Warehousing, Packaging and Other Service Types for the Years 2015, 2025 & 2030
  • EUROPE
    • Bio-pharma Logistics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 74: Europe Recent Past, Current & Future Analysis for Bio-pharma Logistics by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 75: Europe Historic Review for Bio-pharma Logistics by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 76: Europe 15-Year Perspective for Bio-pharma Logistics by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 77: Europe Recent Past, Current & Future Analysis for Bio-pharma Logistics by Type - Cold Chain Logistics and Non-Cold Chain Logistics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Europe Historic Review for Bio-pharma Logistics by Type - Cold Chain Logistics and Non-Cold Chain Logistics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 79: Europe 15-Year Perspective for Bio-pharma Logistics by Type - Percentage Breakdown of Value Sales for Cold Chain Logistics and Non-Cold Chain Logistics for the Years 2015, 2025 & 2030
    • TABLE 80: Europe Recent Past, Current & Future Analysis for Bio-pharma Logistics by Application - Raw Materials & Bulk Pharmaceuticals, Other Applications, Biologics, Prescribed Drugs and Over-the-Counter Medicines - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Europe Historic Review for Bio-pharma Logistics by Application - Raw Materials & Bulk Pharmaceuticals, Other Applications, Biologics, Prescribed Drugs and Over-the-Counter Medicines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 82: Europe 15-Year Perspective for Bio-pharma Logistics by Application - Percentage Breakdown of Value Sales for Raw Materials & Bulk Pharmaceuticals, Other Applications, Biologics, Prescribed Drugs and Over-the-Counter Medicines for the Years 2015, 2025 & 2030
    • TABLE 83: Europe Recent Past, Current & Future Analysis for Bio-pharma Logistics by Service Type - Transportation, Warehousing, Packaging and Other Service Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Europe Historic Review for Bio-pharma Logistics by Service Type - Transportation, Warehousing, Packaging and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 85: Europe 15-Year Perspective for Bio-pharma Logistics by Service Type - Percentage Breakdown of Value Sales for Transportation, Warehousing, Packaging and Other Service Types for the Years 2015, 2025 & 2030
  • FRANCE
    • Bio-pharma Logistics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 86: France Recent Past, Current & Future Analysis for Bio-pharma Logistics by Type - Cold Chain Logistics and Non-Cold Chain Logistics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: France Historic Review for Bio-pharma Logistics by Type - Cold Chain Logistics and Non-Cold Chain Logistics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 88: France 15-Year Perspective for Bio-pharma Logistics by Type - Percentage Breakdown of Value Sales for Cold Chain Logistics and Non-Cold Chain Logistics for the Years 2015, 2025 & 2030
    • TABLE 89: France Recent Past, Current & Future Analysis for Bio-pharma Logistics by Application - Raw Materials & Bulk Pharmaceuticals, Other Applications, Biologics, Prescribed Drugs and Over-the-Counter Medicines - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: France Historic Review for Bio-pharma Logistics by Application - Raw Materials & Bulk Pharmaceuticals, Other Applications, Biologics, Prescribed Drugs and Over-the-Counter Medicines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 91: France 15-Year Perspective for Bio-pharma Logistics by Application - Percentage Breakdown of Value Sales for Raw Materials & Bulk Pharmaceuticals, Other Applications, Biologics, Prescribed Drugs and Over-the-Counter Medicines for the Years 2015, 2025 & 2030
    • TABLE 92: France Recent Past, Current & Future Analysis for Bio-pharma Logistics by Service Type - Transportation, Warehousing, Packaging and Other Service Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: France Historic Review for Bio-pharma Logistics by Service Type - Transportation, Warehousing, Packaging and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 94: France 15-Year Perspective for Bio-pharma Logistics by Service Type - Percentage Breakdown of Value Sales for Transportation, Warehousing, Packaging and Other Service Types for the Years 2015, 2025 & 2030
  • GERMANY
    • Bio-pharma Logistics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 95: Germany Recent Past, Current & Future Analysis for Bio-pharma Logistics by Type - Cold Chain Logistics and Non-Cold Chain Logistics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Germany Historic Review for Bio-pharma Logistics by Type - Cold Chain Logistics and Non-Cold Chain Logistics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 97: Germany 15-Year Perspective for Bio-pharma Logistics by Type - Percentage Breakdown of Value Sales for Cold Chain Logistics and Non-Cold Chain Logistics for the Years 2015, 2025 & 2030
    • TABLE 98: Germany Recent Past, Current & Future Analysis for Bio-pharma Logistics by Application - Raw Materials & Bulk Pharmaceuticals, Other Applications, Biologics, Prescribed Drugs and Over-the-Counter Medicines - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Germany Historic Review for Bio-pharma Logistics by Application - Raw Materials & Bulk Pharmaceuticals, Other Applications, Biologics, Prescribed Drugs and Over-the-Counter Medicines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 100: Germany 15-Year Perspective for Bio-pharma Logistics by Application - Percentage Breakdown of Value Sales for Raw Materials & Bulk Pharmaceuticals, Other Applications, Biologics, Prescribed Drugs and Over-the-Counter Medicines for the Years 2015, 2025 & 2030
    • TABLE 101: Germany Recent Past, Current & Future Analysis for Bio-pharma Logistics by Service Type - Transportation, Warehousing, Packaging and Other Service Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Germany Historic Review for Bio-pharma Logistics by Service Type - Transportation, Warehousing, Packaging and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 103: Germany 15-Year Perspective for Bio-pharma Logistics by Service Type - Percentage Breakdown of Value Sales for Transportation, Warehousing, Packaging and Other Service Types for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 104: Italy Recent Past, Current & Future Analysis for Bio-pharma Logistics by Type - Cold Chain Logistics and Non-Cold Chain Logistics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Italy Historic Review for Bio-pharma Logistics by Type - Cold Chain Logistics and Non-Cold Chain Logistics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 106: Italy 15-Year Perspective for Bio-pharma Logistics by Type - Percentage Breakdown of Value Sales for Cold Chain Logistics and Non-Cold Chain Logistics for the Years 2015, 2025 & 2030
    • TABLE 107: Italy Recent Past, Current & Future Analysis for Bio-pharma Logistics by Application - Raw Materials & Bulk Pharmaceuticals, Other Applications, Biologics, Prescribed Drugs and Over-the-Counter Medicines - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Italy Historic Review for Bio-pharma Logistics by Application - Raw Materials & Bulk Pharmaceuticals, Other Applications, Biologics, Prescribed Drugs and Over-the-Counter Medicines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 109: Italy 15-Year Perspective for Bio-pharma Logistics by Application - Percentage Breakdown of Value Sales for Raw Materials & Bulk Pharmaceuticals, Other Applications, Biologics, Prescribed Drugs and Over-the-Counter Medicines for the Years 2015, 2025 & 2030
    • TABLE 110: Italy Recent Past, Current & Future Analysis for Bio-pharma Logistics by Service Type - Transportation, Warehousing, Packaging and Other Service Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Italy Historic Review for Bio-pharma Logistics by Service Type - Transportation, Warehousing, Packaging and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 112: Italy 15-Year Perspective for Bio-pharma Logistics by Service Type - Percentage Breakdown of Value Sales for Transportation, Warehousing, Packaging and Other Service Types for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Bio-pharma Logistics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 113: UK Recent Past, Current & Future Analysis for Bio-pharma Logistics by Type - Cold Chain Logistics and Non-Cold Chain Logistics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 114: UK Historic Review for Bio-pharma Logistics by Type - Cold Chain Logistics and Non-Cold Chain Logistics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 115: UK 15-Year Perspective for Bio-pharma Logistics by Type - Percentage Breakdown of Value Sales for Cold Chain Logistics and Non-Cold Chain Logistics for the Years 2015, 2025 & 2030
    • TABLE 116: UK Recent Past, Current & Future Analysis for Bio-pharma Logistics by Application - Raw Materials & Bulk Pharmaceuticals, Other Applications, Biologics, Prescribed Drugs and Over-the-Counter Medicines - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: UK Historic Review for Bio-pharma Logistics by Application - Raw Materials & Bulk Pharmaceuticals, Other Applications, Biologics, Prescribed Drugs and Over-the-Counter Medicines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 118: UK 15-Year Perspective for Bio-pharma Logistics by Application - Percentage Breakdown of Value Sales for Raw Materials & Bulk Pharmaceuticals, Other Applications, Biologics, Prescribed Drugs and Over-the-Counter Medicines for the Years 2015, 2025 & 2030
    • TABLE 119: UK Recent Past, Current & Future Analysis for Bio-pharma Logistics by Service Type - Transportation, Warehousing, Packaging and Other Service Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 120: UK Historic Review for Bio-pharma Logistics by Service Type - Transportation, Warehousing, Packaging and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 121: UK 15-Year Perspective for Bio-pharma Logistics by Service Type - Percentage Breakdown of Value Sales for Transportation, Warehousing, Packaging and Other Service Types for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 122: Rest of Europe Recent Past, Current & Future Analysis for Bio-pharma Logistics by Type - Cold Chain Logistics and Non-Cold Chain Logistics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Rest of Europe Historic Review for Bio-pharma Logistics by Type - Cold Chain Logistics and Non-Cold Chain Logistics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 124: Rest of Europe 15-Year Perspective for Bio-pharma Logistics by Type - Percentage Breakdown of Value Sales for Cold Chain Logistics and Non-Cold Chain Logistics for the Years 2015, 2025 & 2030
    • TABLE 125: Rest of Europe Recent Past, Current & Future Analysis for Bio-pharma Logistics by Application - Raw Materials & Bulk Pharmaceuticals, Other Applications, Biologics, Prescribed Drugs and Over-the-Counter Medicines - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Rest of Europe Historic Review for Bio-pharma Logistics by Application - Raw Materials & Bulk Pharmaceuticals, Other Applications, Biologics, Prescribed Drugs and Over-the-Counter Medicines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 127: Rest of Europe 15-Year Perspective for Bio-pharma Logistics by Application - Percentage Breakdown of Value Sales for Raw Materials & Bulk Pharmaceuticals, Other Applications, Biologics, Prescribed Drugs and Over-the-Counter Medicines for the Years 2015, 2025 & 2030
    • TABLE 128: Rest of Europe Recent Past, Current & Future Analysis for Bio-pharma Logistics by Service Type - Transportation, Warehousing, Packaging and Other Service Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Rest of Europe Historic Review for Bio-pharma Logistics by Service Type - Transportation, Warehousing, Packaging and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 130: Rest of Europe 15-Year Perspective for Bio-pharma Logistics by Service Type - Percentage Breakdown of Value Sales for Transportation, Warehousing, Packaging and Other Service Types for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Bio-pharma Logistics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 131: Asia-Pacific Recent Past, Current & Future Analysis for Bio-pharma Logistics by Type - Cold Chain Logistics and Non-Cold Chain Logistics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Asia-Pacific Historic Review for Bio-pharma Logistics by Type - Cold Chain Logistics and Non-Cold Chain Logistics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 133: Asia-Pacific 15-Year Perspective for Bio-pharma Logistics by Type - Percentage Breakdown of Value Sales for Cold Chain Logistics and Non-Cold Chain Logistics for the Years 2015, 2025 & 2030
    • TABLE 134: Asia-Pacific Recent Past, Current & Future Analysis for Bio-pharma Logistics by Application - Raw Materials & Bulk Pharmaceuticals, Other Applications, Biologics, Prescribed Drugs and Over-the-Counter Medicines - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Asia-Pacific Historic Review for Bio-pharma Logistics by Application - Raw Materials & Bulk Pharmaceuticals, Other Applications, Biologics, Prescribed Drugs and Over-the-Counter Medicines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 136: Asia-Pacific 15-Year Perspective for Bio-pharma Logistics by Application - Percentage Breakdown of Value Sales for Raw Materials & Bulk Pharmaceuticals, Other Applications, Biologics, Prescribed Drugs and Over-the-Counter Medicines for the Years 2015, 2025 & 2030
    • TABLE 137: Asia-Pacific Recent Past, Current & Future Analysis for Bio-pharma Logistics by Service Type - Transportation, Warehousing, Packaging and Other Service Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Asia-Pacific Historic Review for Bio-pharma Logistics by Service Type - Transportation, Warehousing, Packaging and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 139: Asia-Pacific 15-Year Perspective for Bio-pharma Logistics by Service Type - Percentage Breakdown of Value Sales for Transportation, Warehousing, Packaging and Other Service Types for the Years 2015, 2025 & 2030
  • REST OF WORLD
    • TABLE 140: Rest of World Recent Past, Current & Future Analysis for Bio-pharma Logistics by Type - Cold Chain Logistics and Non-Cold Chain Logistics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Rest of World Historic Review for Bio-pharma Logistics by Type - Cold Chain Logistics and Non-Cold Chain Logistics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 142: Rest of World 15-Year Perspective for Bio-pharma Logistics by Type - Percentage Breakdown of Value Sales for Cold Chain Logistics and Non-Cold Chain Logistics for the Years 2015, 2025 & 2030
    • TABLE 143: Rest of World Recent Past, Current & Future Analysis for Bio-pharma Logistics by Application - Raw Materials & Bulk Pharmaceuticals, Other Applications, Biologics, Prescribed Drugs and Over-the-Counter Medicines - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Rest of World Historic Review for Bio-pharma Logistics by Application - Raw Materials & Bulk Pharmaceuticals, Other Applications, Biologics, Prescribed Drugs and Over-the-Counter Medicines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 145: Rest of World 15-Year Perspective for Bio-pharma Logistics by Application - Percentage Breakdown of Value Sales for Raw Materials & Bulk Pharmaceuticals, Other Applications, Biologics, Prescribed Drugs and Over-the-Counter Medicines for the Years 2015, 2025 & 2030
    • TABLE 146: Rest of World Recent Past, Current & Future Analysis for Bio-pharma Logistics by Service Type - Transportation, Warehousing, Packaging and Other Service Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Rest of World Historic Review for Bio-pharma Logistics by Service Type - Transportation, Warehousing, Packaging and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 148: Rest of World 15-Year Perspective for Bio-pharma Logistics by Service Type - Percentage Breakdown of Value Sales for Transportation, Warehousing, Packaging and Other Service Types for the Years 2015, 2025 & 2030

IV. COMPETITION